Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections
Recruiting
Observational Study
Overactive Bladder (OAB)
Urge Incontinence
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 55 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 40 (estimated)
- Sponsor
- Alexis Dieter · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Single-site prospective observational pilot feasibility study of women with overactive bladder/urge urinary incontinence undergoing onabotulinum toxin type A intradetrusor injections in order to achieve the following objectives:
* Establish a record of successful collaboration with Dr. Ravel, an expert researcher in the female microbiome based at the University of Maryland
* Demonstrate the inves…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Natal female \> 55 years old
* English-speaking
* Scheduled to undergo onabotulinum toxin type A for treatment of OAB
* No menses for \>1 year if uterus in situ
* Planning one dose nitrofurantoin for antibiotic prophylaxis at time of onabotulinum toxin type A injection per cli…
Contacts
No contact information available.